Study of lung and airway disease diagnosis
Part of Lungs & breathing clinical trials.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 80 years old.
- You must have a diagnosis of COPD, idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, or a related condition.
- You need to complete lung function tests and a high-resolution CT scan of your chest within one month before you are discharged (if you are in the hospital) or as an outpatient.
- You must not have a life expectancy of less than 12 months.
- You cannot be pregnant or breastfeeding, and you must not have had a lobe of your lung removed or radiation therapy to your chest.
- You must provide informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the lungs of people with airway disease to healthy volunteers to understand inflammation and lung function. You may be eligible if you have airway disease or are a healthy adult.
This study uses a new imaging technology called LIBS to examine lung tissue samples that were already removed as part of your regular care. The goal is to see if this method can help doctors better understand and diagnose chronic lung diseases like interstitial lung disease, sarcoidosis, or emphysema.
This study uses a lung wash (bronchoalveolar lavage) to look at the types of immune cells in the lungs of people with certain lung scarring diseases called interstitial lung diseases (ILD). It may help doctors better understand different ILD types and guide treatment.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This study is testing a new way to speed up the diagnosis of interstitial lung disease (a group of lung scarring conditions). If you have symptoms or scan findings that suggest ILD but haven't been fully diagnosed yet, this trial may help you get a faster, clearer answer.
This study follows people with interstitial lung disease to learn more about how Chinese medicine can help. If you have ILD and are 18 or older, you may be able to join.
Hear when a new Airway Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.